Question 1

What are the most cited papers from GALENpharma (Germany)?

Accepted Answer

The most cited paper from GALENpharma (Germany) is "IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma" (Zhi‐Zhang Yang, Deanna M. Grote, Steven C. Ziesmer et al., 2012), with 308 citations. Next come "Involvement of Galectin-9 in Guinea Pig Allergic Airway Inflammation" (32) and "Galectin-9 Changes Its Function to Maintain Homeostasis" (3).

Question 2

Which research topics does GALENpharma (Germany) publish most on?

Accepted Answer

By volume: Galectins and Cancer Biology, Redox biology and oxidative stress, Free Radicals and Antioxidants and Macrophage Migration Inhibitory Factor.

Question 3

Which fields of science does GALENpharma (Germany) work in?

Accepted Answer

In all years, 85% of research at GALENpharma (Germany) is in Life Sciences, 15% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (45%), Immunology and Microbiology (40%), Chemistry (15%). It does 1.4× the world's share of Life Sciences.

Question 4

Is GALENpharma (Germany)'s research output growing?

Accepted Answer

Output in 2022-2025 was 100% lower than in 2018-2021.